Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons by Naimi, Adel, Mohammed, Rebar N, Raji, Ahmed, Chupradit, Supat, Yumashev, Alexei Valerievich, Suksatan, Wanich, Shalaby, Mohammed Nader, Thangavelu, Lakshmi, Kamrava, Siavash, Shomali, Navid, Sohrabi, Armin D, Adili, Ali, Noroozi-Aghideh, Ali, Razeghian, Ehsan

Get full text